Eli Lilly / Eli Lilly and Company / Merck / OMERACT / GSK / Takeda / UCB / Boehringer Ingelheim / The Rheumatoid Arthritis Working Group / Novo Nordisk / SDG LLC / /
Country
United States / /
Event
Business Partnership / /
Facility
National Institute of Arthritis / Critical Path Institute / Johns Hopkins University / American College of Rheumatology / /
European League Against Rheumatism / Musculoskeletal and Skin Diseases / United Nations / Division of Pulmonary / Allergy / and Rheumatology Products / U.S. Food and Drug Administration / the American College / Johns Hopkins University / Rheumatic Disease Research Core Center / Critical Path Institute / National Institute of Arthritis and Musculoskeletal / Global Alliance / /
Person
Johns Hopkins / Lee S. Simon / Ashley F. Slagle / Clifton O. Bingham / Sarah Yim / Risa Hayes / /
Position
Senior Research Scientist / Global Patient Outcomes / Director / Associate Director / COA Qualification Scientific Coordinator / Advisor / Global Patient Outcomes / General / President & CEO / Spokesperson & Director of Strategic Relations / Associate Professor / Professor of Medicine / /
Lessons Learned from the PRO Consortium Along the Path to PRO Instrument Qualification: Case Study - FINAL